|Dr. Raymond Barlow||CEO & Director||435k||N/A||1969|
|Mr. Steven Medlicott||CFO, Fin. Director & Exec. Director||287k||N/A||1965|
|Mr. Jonny Wray||Head of Discovery Informatics||N/A||N/A||N/A|
|Mr. Colin Stubberfield||Head of Drug Discovery||N/A||N/A||N/A|
|Mr. Alan Whitmore||Head of Discovery Biology||N/A||N/A||N/A|
e-Therapeutics plc engages in the discovery of drugs through its proprietary network-driven drug discovery platform in the United Kingdom. It is developing two NDD-derived immuno-oncology programs, including tryptophan catabolism and immune checkpoint modulation. The company, through its subsidiary, Searchbolt Limited, develops search engine technology. The company has collaborations with C4X Holdings PLC, Intellegens, Biorelate, and Novo Nordisk. e-Therapeutics plc was founded in 2001 and is based in Long Hanborough, the United Kingdom.
e-Therapeutics plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.